Atlas Trials

Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy

Clinical trial NCT02423811 · COMPLETED

Trial details

NCT number
NCT02423811
Sponsor
National Cheng-Kung University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer Stem Cell
Start date
2015-04-01
Primary completion
2017-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.